Integreview IRB

IRBs react to new model for registering proposed gene trials

Monday, May 2, 2016

On April 27, the National institutes of Health (NIH) enacted a new administrative model for the review of proposed human gene trials; the new guidelines upend a process that has been in place for more than 40 years. Predictably, reaction throughout the industry is mixed. Larger firms are adjusting quickly to the change and retooling their processes to comply with the new model. At the other end of the spectrum, some IRBs, including IntegReview, declined to comment on the changes, stating that the matter is still under internal review.

[Read More]

Verified Clinical Trials, Integreview IRB create new expedited research subject authorization review process

Thursday, May 21, 2015

Verified Clinical Trials (VCT) and Integreview IRB have developed a preferred partnership to stop dual enrollment in clinical trials and reduce protocol deviations while promoting safety. Research sites, CROs and pharmaceutical sponsors will benefit from this alliance in an effort to stop dual enrollment in clinical trials and reduce significant protocol violations from occurring. 

[Read More]